SEARCH

SEARCH BY CITATION

References

  • 1
    Myers LB, Midence K. Concepts and issues in adherence. In: MyersLB, MidenceK, eds. Adherence to Treatment in Medical Conditions. Amsterdam: Harwood Academic Publishers; 1998: 124.
  • 2
    Shumaker SA, Schron EB, Ockene JK, McBee WL , eds. The Handbook of Health Behavior Change. 2nd ed. New York: Springer Publishing Company, Inc.; 1998.
  • 3
    Haynes RB. Strategies to improve compliance with referrals, appointments, and prescribed medical regimens. In: HaynesRB, TaylorDW, SackettDL, eds. Compliance in Health Care. Baltimore, Md: The Johns Hopkins University Press; 1979: 12143.
  • 4
    Poisal JA, Murray L. Growing differences between Medicare beneficiaries with and without drug coverage. Health Aff (Millwood). 2001;20: 7485.
  • 5
    Stuart B, Grana J. Ability to pay and the decision to medicate. Med Care. 1998;36: 20211.
  • 6
    Blustein J. Drug coverage and drug purchases by Medicare beneficiaries with hypertension. Health Aff (Millwood). 2000;19: 21930.
  • 7
    Adams AS, Soumerai SB, Ross-Degnan D. Use of antihypertensive drugs by Medicare enrollees: does type of drug coverage matter? Health Aff (Millwood). 2001;20: 27686.
  • 8
    Lillard LA, Rogowski J, Kington R. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population. Med Care. 1999;37: 92636.
  • 9
    Department of Health & Human Services. Report to the President: Prescrition Drug Coverage, Spending, Utilization, and Prices. 2000. http://www.aspe.hhs.gov/health/reports/drugstudy.
  • 10
    Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among Medicare beneficiaries. Health Aff (Millwood). 2003;22: 2209.
  • 11
    Heisler M, Langa KM, Eby EL, Fendrick AM, Kabeto MU, Piette JD. The health effects of restricting prescription medication use because of cost. Med Care. 2004;42: 62634.
  • 12
    Piette JD, Heisler M, Wagner TH. Cost-related medication underuse among chronically ill adults: the treatments people forgo, how often, and who is at risk. Am J Public Health. 2004;94: 17827.
  • 13
    Safran DG, Neuman P, Schoen C , et al. Prescription drug coverage and seniors: how well are states closing the gap. Health Aff (Millwood). 2002;W25367.
  • 14
    Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16: 7939.
  • 15
    Safran DG, Wilson IB, Rogers WH, Montgomery JE, Chang H. Primary care quality in the Medicare Program: comparing the performance of Medicare health maintenance organizations and traditional fee-for-service medicare. Arch Intern Med. 2002;162: 75765.
  • 16
    Dillman DA. Mail and Telephone Surveys: the Total Design Method. New York, NY: John Wiley & Sons; 1978.
  • 17
    Aday LA, Andersen R. Development of Indices of Access to Medical Care. Ann Arbor, Mich: Health Administration Press; 1975.
  • 18
    Andersen RM. A Behavioral Model of Families' Use of Health Services, Research Series No. 25. Chicago, Ill: Center for Health Administration Studies, University of Chicago; 1968.
  • 19
    Safran DG, Kosinski M, Tarlov AR , et al. The primary care assessment survey: tests of data quality and measurement performance. Med Care. 1998;36: 72839.
  • 20
    Murphy J, Chang H, Montgomery JE, Rogers WH, Safran DG. The quality of physician–patient relationships. Patients' experiences 1996–1999. J Fam Pract. 2001;50: 1239.
  • 21
    National Center for Health Statistics. Current Estimates from the National Health Interview Survey. Washington, DC: U.S. Government; 1993.
  • 22
    McHorney CA, Ware JEJ, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31: 24763.
  • 23
    Jones MP. Indicator and stratification methods for missing explanatory variables in multiple linear regression. J Am Stat Assoc. 1996;91: 22230.
  • 24
    Greene WH. Econometric Analysis 1993. New York, NY: Macmillan Publishing Company; 1993.
  • 25
    Safran DG. Defining the future of primary care: what can we learn from patients? Ann Intern Med. 2003;138: 24855.
  • 26
    Report to the Congress: Selected Medicare Issues. Washington, DC: Medicare Payment Advisory Commission; 2000.
  • 27
    Pear R. 17 percent increase in prescription drug costs hit elderly hardest, study finds. The New York Times. June 27, 2002.
  • 28
    Strunk BC, Ginsburg PB, Gabel JR. Tracking health care costs. Health Aff (Millwood). 2002; (suppl): W3950.
  • 29
    Connolly C. Pharmaceutical spending continues stady increase: a few heavily advertised and high-priced “blockbuster” medications drive 17 percent increase. Washington Post. March 29, 2002:09.
  • 30
    Achman L, Gold M. Trends in Medicare+Choice: Benefits and Premiums, 1999–2002. New York, NY: The Commonwealth Fund; 2002.
  • 31
    Alexander GC, Casalino LP, Meltzer DO. Patient–physician communication about out-of-pocket costs. JAMA. 2003;290: 9538.
  • 32
    Piette JD, Heisler M, Wagner TH. Cost-related medication underuse: do patients with chronic illnesses tell their doctors? Arch Intern Med. 2004;164: 174955.
  • 33
    Maxwell S, Baseggio C. Outpatient Therapy Services Under Medicare: Background and Policy Issues. Washington, DC: The Urban Institute; 2000.
  • 34
    Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2002;288: 298197.